Future of evidence ecosystem series: 3. From an evidence synthesis ecosystem to an evidence ecosystem.

Journal of Clinical Epidemiology
Philippe RavaudIsabelle Boutron

Abstract

The "one-off" approach of systematic reviews is no longer sustainable; we need to move toward producing "living" evidence syntheses (i.e., comprehensive, based on rigorous methods, and up-to-date). This implies rethinking the evidence synthesis ecosystem, its infrastructure, and management. The three distinct production systems-primary research, evidence synthesis, and guideline development-should work together to allow for continuous refreshing of synthesized evidence and guidelines. A new evidence ecosystem, not just focusing on synthesis, should allow for bridging the gaps between evidence synthesis communities, primary researchers, guideline developers, health technology assessment agencies, and health policy authorities. This network of evidence synthesis stakeholders should select relevant clinical questions considered a priority topic. For each question, a multidisciplinary community including researchers, health professionals, guideline developers, policymakers, patients, and methodologists needs to be established and commit to performing the initial evidence synthesis and keeping it up-to-date. Encouraging communities to work together continuously with bidirectional interactions requires greater incentives, rewards, an...Continue Reading

References

Jul 15, 2005·JAMA : the Journal of the American Medical Association·John P A Ioannidis
Sep 19, 2006·Statistics in Medicine·Alexander J SuttonKeith R Abrams
May 16, 2008·The New England Journal of Medicine·Dean A FergussonUNKNOWN BART Investigators
Feb 27, 2009·JAMA : the Journal of the American Medical Association·Pierluigi TricociSidney C Smith
Oct 16, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Abdur Rahman KhanImad M Tleyjeh
Jan 12, 2011·Archives of Internal Medicine·Dong Heun Lee, Ole Vielemeyer
Apr 25, 2013·Science Translational Medicine·Joseph V SelbyFrancis S Collins
Sep 13, 2014·Science·Robert F TerryChristopher Dye
Apr 13, 2017·The New England Journal of Medicine·Barbara E BiererHeather H Pierce
Sep 16, 2017·Journal of Clinical Epidemiology·Elie A AklUNKNOWN Living Systematic Review Network
Jun 22, 2018·Nature·William J Sutherland, Claire F R Wordley
Jun 22, 2018·Nature·Christl A DonnellyChris Wormald
Feb 19, 2019·JAMA Internal Medicine·Ross C SchumacherAnil N Makam
Mar 16, 2019·JAMA : the Journal of the American Medical Association·Alexander C FanaroffRenato D Lopes

❮ Previous
Next ❯

Citations

Dec 11, 2020·The Cochrane Database of Systematic Reviews·John HiltonKarla Soares-Weiser
Sep 16, 2020·Annals of Internal Medicine·Isabelle BoutronUNKNOWN COVID-NMA Consortium
Apr 27, 2021·Scientometrics·Guillaume CabanacIsabelle Boutron
May 17, 2021·Current Opinion in Allergy and Clinical Immunology·Bayanne Olabi, Hywel C Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.